Company Summary
NVasc, Inc. is an ophthalmology company developing a therapeutic protein designed to re-vascularize the retina and choroid, addressing the underlying cause of many retinal diseases, including age-related macular degeneration. Its lead program is a LIF fusion protein intended to encourage the growth of healthy, non-leaking blood vessels in the eye.